CRL
Charles River Laboratories InternationalยทNYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CRL Profile
Charles River Laboratories International, Inc.
A leading global provider of solutions that accelerate the early-stage drug discovery and development process
Life Science Tools and Services
--
06/23/2000
New York Stock Exchange
20,100
12-31
Common stock
251 Ballardvale Street, Wilmington, Massachusetts 01887
--
Charles River Laboratories International, Inc., which began operations in 1947, is a Delaware corporation. The company is a leading non-clinical global drug development partner with a mission to create healthier lives. Building on their original core competencies in laboratory animal medicine and science (research model technology), the company has developed a diverse portfolio of discovery and security assessment services, including good laboratory practice (GLP) and non-GLP, to support clients from target identification to non-clinical development. Leveraging their broad portfolio of products and services enables clients to create more efficient and flexible drug development models, thereby reducing their costs, increasing their productivity and effectiveness, and increasing their speed to market.
